TotalMarketCap

Maravai Lifesciences

MRVINasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.809 B

$6.97 -9.78%

Close of 6 Nov 2026

As of 6 Nov 2026, Maravai Lifesciences (MRVI) has a market capitalization of $1.81B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$185.7M

#2294 by revenue

Earnings

-$130.8M

Loss-making

Shares outstanding

147,839,000

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #99Sarepta TherapeuticsSRPT$1.85B
  2. #100Trevi TherapeuticsTRVI$1.84B
  3. #101Maravai LifesciencesMRVI$1.81B
  4. #102Stoke TherapeuticsSTOK$1.70B
  5. #103Zenas BioPharmaZBIO$1.70B

What if Maravai Lifesciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$108,739.86

Per share 15,612× higher

Bitcoin $1.53T

$5,883.72

Per share 845× higher

Apple $5.02T

$19,315.72

Per share 2,773× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Maravai Lifesciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.